|
|
Volumn 68, Issue 7, 2012, Pages 1103-1107
|
|
Bevacizumab-induced serious side-effects: A review of the French pharmacovigilance database
a
|
|
Author keywords
Adverse drug reaction; Bevacizumab; Pharmacovigilance; VEGF
|
|
Indexed keywords
BEVACIZUMAB;
ADULT;
AGED;
ANEMIA;
APLASIA;
ARTICLE;
BILIARY TRACT DISEASE;
BLEEDING;
BRAIN CANCER;
BRAIN DISEASE;
BRAIN HEMORRHAGE;
CANCER CHEMOTHERAPY;
CARDIOMYOPATHY;
CARDIOVASCULAR DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CEREBROVASCULAR ACCIDENT;
CHILD;
COLORECTAL CANCER;
DATA BASE;
DISABILITY;
DISEASE SEVERITY;
DRUG EXPOSURE;
DRUG FEVER;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
EDEMA;
ENDOCARDIAL DISEASE;
EPISTAXIS;
ERYTHROCYTE DISORDER;
FEMALE;
FRANCE;
GASTROINTESTINAL DISEASE;
HEART ARRHYTHMIA;
HEART FAILURE;
HEART INFARCTION;
HEMOPTYSIS;
HUMAN;
HYPERTENSION;
INFECTION;
INTESTINAL BLEEDING;
INTESTINE PERFORATION;
KIDNEY CANCER;
LEUKOCYTE DISORDER;
LEUKOPENIA;
LIVER DISEASE;
LUNG CANCER;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
METABOLIC DISORDER;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
MUSCULOSKELETAL DISEASE;
MYOCARDIAL DISEASE;
NEUROPATHY;
NUTRITIONAL DISORDER;
PARALYSIS;
PARESTHESIA;
PERICARDIAL DISEASE;
PERIPHERAL NEUROPATHY;
PERITONITIS;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RESPIRATORY TRACT DISEASE;
RETICULOENDOTHELIOSIS;
RISK ASSESSMENT;
SKIN APPENDAGE DISEASE;
SKIN DISEASE;
THROMBOCYTE DISORDER;
THROMBOEMBOLISM;
TREATMENT DURATION;
TREATMENT OUTCOME;
URINARY TRACT DISEASE;
VALVULAR HEART DISEASE;
VASCULAR DISEASE;
ADOLESCENT;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHILD;
CHILD, PRESCHOOL;
DATABASES, FACTUAL;
DRUG TOXICITY;
FEMALE;
FRANCE;
HUMANS;
MALE;
MIDDLE AGED;
PHARMACOVIGILANCE;
YOUNG ADULT;
|
|
EID: 84864280912
PISSN: 00316970
EISSN: 14321041
Source Type: Journal
DOI: 10.1007/s00228-012-1232-7 Document Type: Article |
|
Times cited : (60)
|
|
References (13)
|
